Lakewood-Amedex Biotherapeutics, Inc. (LABT)
2.22
+0.17
(+8.29%)
USD |
NASDAQ |
Sep 11, 16:00
2.15
-0.07
(-3.15%)
Pre-Market: 09:08
Lakewood-Amedex Biotherapeutics Total Liabilities (Quarterly) : 0.6289M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6289M |
| March 31, 2026 | 3.038M |
| December 31, 2025 | 2.446M |
| September 30, 2025 | 2.251M |
| Date | Value |
|---|---|
| June 30, 2025 | 2.241M |
| March 31, 2025 | 0.8941M |
| December 31, 2024 | 0.661M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.96M |
| Shareholders Equity (Quarterly) | 4.331M |
| Debt to Equity Ratio | 0.0235 |
| Current Ratio | 7.704 |
| Net Debt Paydown Yield | 1.01% |